v3.25.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
Total
Common Stock
Capital in Excess of Par Value
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balances at Dec. 31, 2023 $ 4,157,457,000 $ 1,826,000 $ 4,971,625,000 $ (805,883,000) $ (10,111,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 94,371,000     94,371,000  
Dividends declared and paid:          
Common stock dividends declared and paid (101,948,000)   736,000 (102,684,000)  
Issuance of common stock:          
Director compensation 320,000   320,000    
Stock purchase plan 32,000   32,000    
ATM equity program 20,925,000 5,000 20,920,000    
Restricted shares, net of forfeitures   4,000 (4,000)    
Stock issuance costs (178,000)   (178,000)    
Amortization of deferred compensation 3,247,000   3,247,000    
Amortization of interest rate hedges 632,000       632,000
Fair value of forward starting swap 0        
Balances at Mar. 31, 2024 4,174,858,000 1,835,000 4,996,698,000 (814,196,000) (9,479,000)
Balances at Dec. 31, 2024 4,362,275,000 1,877,000 5,197,644,000 (829,287,000) (7,959,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 96,458,000     96,458,000  
Dividends declared and paid:          
Common stock dividends declared and paid     605,000 (108,335,000)  
Common stock dividends declared and paid (107,730,000)        
Issuance of common stock:          
Director compensation 268,000   268,000    
Stock purchase plan 50,000   50,000    
Restricted shares, net of forfeitures   4,000 (4,000)    
Stock issuance costs (85,000)   (85,000)    
Amortization of deferred compensation 5,083,000   5,083,000    
Amortization of interest rate hedges 460,000       460,000
Fair value of forward starting swap (292,000)       (292,000)
Balances at Mar. 31, 2025 $ 4,356,487,000 $ 1,881,000 $ 5,203,561,000 $ (841,164,000) $ (7,791,000)